Mukta Arora, MB, BS
- Medicare services, 2021
- 76
- Part D claims, 2021
- 277
- Publications
- 162
- Clinical trials
- 3
- Industry payments
- $550
- Practice address
- 516 Delaware Street Se, Minneapolis, MN 55455
- Practice phone
- Call (612) 273-2800
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Mukta Arora's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Mukta Arora is a hematologist and oncologist in Minneapolis, Minnesota
Mukta Arora practices in Minneapolis, Minnesota.
Mukta Arora's NPI, 1073557278, was assigned on June 16, 2006. Mukta Arora holds Minnesota license 44897.
- NPI
- 1073557278NPI Registry (opens in a new tab)
- NPI enumeration date
- June 16, 2006
- NPI status
- Active
- Practice phone
- (612) 273-2800
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Mukta Arora's practice address is in Minneapolis, Minnesota
Mukta Arora's practice address in the NPI Registry is 516 Delaware Street Se, Minneapolis, MN 55455. The practice phone is (612) 273-2800.
- NPI Registry address516 Delaware Street Se, Minneapolis, MN 55455Phone(612) 273-2800
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Mukta Arora's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Mukta Arora practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mukta Arora's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Mukta Arora is one of 213 hematologists and oncologists in Minnesota
Hematology and oncology is Mukta Arora's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Mukta Arora is licensed in Minnesota.
Specialties and state licenses
- Hematology and oncology, MinnesotaPrimary
Hematologists and oncologists near Mukta Arora
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Mukta Arora billed Medicare for 76 services in 2021
CMS data shows 76 Medicare services from Mukta Arora across 1 procedure code in 2021, all of them office visits. Medicare paid $6,010 for them. Every service was in a facility, such as a hospital, rather than an office.
Mukta Arora's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 1892021: 7660%
Mukta Arora compared with the Minnesota median for hematologists and oncologists, 2021
- Mukta Arora
- Minnesota median
- Medicare services
- 76vs 38480% below
- Part D claims
- 277vs 32816% below
Medians across 209 hematologists and oncologists in Minnesota with Dmand AI profiles that report each measure.
Mukta Arora's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Mukta Arora?
Medicare shows one payer. Book a meeting to get commercial claims data for Mukta Arora and other hematologists and oncologists in Minnesota.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Mukta Arora wrote 277 Medicare Part D claims in 2021
In 2021, Mukta Arora wrote 277 Medicare Part D claims. They cover 10 drugs, with $440,491 in total drug cost. In 2020, CMS named 289 claims across 11 drugs.
Mukta Arora's most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2021
- 2020
- 2021
- Claims for drugs CMS names
- 2020: 2892021: 2774%
Drugs named by CMS: 10 in 2021, 11 in 2020.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Mukta Arora has 162 publications on record
Dmand AI links 162 papers to Mukta Arora, published from 2007 to 2025. 2018 was the busiest year, with 17. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation, Homologous. Mukta Arora has published most often in Biol Blood Marrow Transplant. Mukta Arora's most frequent co-authors are Daniel J. Weisdorf, MD, Joseph Anthony Pidala, MD and Margaret L. MacMillan, MD.
Mukta Arora's papers by year, 2016 to 2025
Topics Mukta Arora writes about most
- Hematopoietic Stem Cell Transplantation
- Graft vs Host Disease
- Transplantation, Homologous
- Transplantation Conditioning
- Bone Marrow Transplantation
- Hematologic Neoplasms
- Bone Marrow
- Cord Blood Stem Cell Transplantation
Mukta Arora's most frequent co-authors
- Daniel J. Weisdorf, MD67 shared papers
- Joseph Anthony Pidala, MD42 shared papers
- Margaret L. MacMillan, MD33 shared papers
Recent publications by Mukta Arora
Transplant Cell Ther
Eur J Pharm Biopharm
See who Mukta Arora researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Mukta Arora works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Mukta Arora has worked on 3 clinical trials
Dmand AI links Mukta Arora to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Bronchiolitis Obliterans Syndrome, Organizing Pneumonia and Hematologic Neoplasms. Fred Hutchinson Cancer Center sponsors the most, 2.
Clinical trials with Mukta Arora by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Mukta Arora's trials
- Bronchiolitis Obliterans Syndrome
- Organizing Pneumonia
- Hematologic Neoplasms
- Hematologic Diseases
Investigators on the most trials with Mukta Arora
- Joseph Anthony Pidala, MD2 shared trials
- Melissa Alsina, MD1 shared trial
- Claudio Anasetti, MD1 shared trial
Recent clinical trials with Mukta Arora
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases (opens in a new tab)
Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Mukta Arora received $550 in industry payments from 2016 to 2020
CMS Open Payments shows 4 general payments to Mukta Arora from 3 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 91% of the total. 3M Company paid the most, $500.
General payments to Mukta Arora by program year, 2016 to 2020
General payments to Mukta Arora by kind, 2016 to 2020
- Consulting fees$50091%
- Education$509%
Companies that paid Mukta Arora the most, 2016 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Mukta Arora's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Mukta Arora
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Mukta Arora's NPI number?
Mukta Arora's NPI number is 1073557278. It was assigned on June 16, 2006, and it is active in the NPI Registry.
What does Mukta Arora specialize in?
Mukta Arora is a hematologist and oncologist in Minneapolis, Minnesota. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Mukta Arora practice?
Mukta Arora practices at 516 Delaware Street Se, Minneapolis, MN 55455.
What is Mukta Arora's office phone number?
The practice phone on file for Mukta Arora is (612) 273-2800.
What is Mukta Arora's medical license number?
Mukta Arora holds Minnesota license 44897.
Does Mukta Arora accept Medicare?
Yes. CMS data shows Mukta Arora billed Medicare for 76 services in 2021.
What services does Mukta Arora bill to Medicare?
In 2021, Mukta Arora's most billed Medicare services were office visit, established patient (99214).
What drugs does Mukta Arora prescribe most?
In 2021 Medicare Part D data, Mukta Arora's most prescribed drugs by claims were Prednisone, Sulfamethoxazole-Trimethoprim and Fluconazole.
Has Mukta Arora received payments from drug or device companies?
CMS Open Payments shows $550 in general payments to Mukta Arora from 3 companies from 2016 to 2020. The largest total came from 3M Company.
How long has Mukta Arora been practicing?
Mukta Arora's NPI was assigned in 2006.
Does Mukta Arora do research?
Dmand AI links 162 publications to Mukta Arora, published from 2007 to 2025. Mukta Arora has worked on 3 clinical trials.
Who does Mukta Arora publish with?
Mukta Arora's most frequent co-authors are Daniel J. Weisdorf, MD (67 shared papers), Joseph Anthony Pidala, MD (42 shared papers) and Margaret L. MacMillan, MD (33 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Minnesota by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card